TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32591869

Group type: COMPARATOR
Intervention: Demineralized bovine bone mineral (DBBM) and a gingival soft tissue punch
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Demineralized bovine bone mineral (DBBM) and a hemostatic gelatin sponge
Number of subjects: 21
Study: 32128907

Group type: EXPERIMENTAL
Intervention: Topical rapamycin solution (1 mg/mL) applied twice daily for 3 months
Number of subjects: 76

Group type: COMPARATOR
Intervention: Betamethasone dipropionate ointment 0.05% in Orabase® applied twice daily for 3 months
Number of subjects: 76
Study: 34716281

Group type: EXPERIMENTAL
Intervention: Timapiprant
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32209911

Group type: EXPERIMENTAL
Intervention: Simultaneous resection
Number of subjects: 105

Group type: COMPARATOR
Intervention: Delayed resection
Number of subjects: 105
Study: 34855053

Group type: EXPERIMENTAL
Intervention: Self-referential future thinking induction
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Self-referential past thinking induction
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 63
Study: 32460815

Group type: EXPERIMENTAL
Intervention: Stratification by centre for clustering management
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Defining a minimum expertise level for treatment provider
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Experience in expertise-based designs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Adjustment for clustering during analysis
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Analysis of learning
Number of subjects: 50
Study: 36088327

Group type: EXPERIMENTAL
Intervention: sST2 ≥ 32.0 ng/mL
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: sST2 16.5–32.0 ng/mL
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: NT-proBNP ≥ 337 ng/L
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: NT-proBNP 89–337 ng/L
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: hs-cTnI ≥ 7.8 ng/L
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: Cardiac score based on sST2, hs-cTnI, and NT-proBNP
Number of subjects: 568

Group type: EXPERIMENTAL
Intervention: sST2, hs-cTnI, and NT-proBNP
Number of subjects: 568
Study: 34675189

Group type: EXPERIMENTAL
Intervention: 20 mg methylphenidate (MPH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34619447

Group type: EXPERIMENTAL
Intervention: URH+CM (Contingency Management)
Number of subjects: 98

Group type: COMPARATOR
Intervention: URH (Control)
Number of subjects: 98
Study: 34245689

Group type: EXPERIMENTAL
Intervention: IgG
Number of subjects: 36000

Group type: EXPERIMENTAL
Intervention: IgA
Number of subjects: 36000

Group type: EXPERIMENTAL
Intervention: IgM
Number of subjects: 36000
Study: 35962359

Group type: EXPERIMENTAL
Intervention: Conversations with primary care nurses about child's weight (responsive, non-blaming approach).
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Conversations with primary care nurses about child's weight (presentation of the topic).
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Conversations with primary care nurses about child's weight.
Number of subjects: 17
Study: 34358372

Group type: EXPERIMENTAL
Intervention: DenseNet121 model
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Faster R‐CNN model
Number of subjects: 700
Study: 35143411

Group type: EXPERIMENTAL
Intervention: 500 mg/L buffered MS‐222 for 15 minutes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1000 mg/L buffered MS‐222 for 15 minutes
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1000 mg/L buffered MS‐222 for 15 minutes, then placed in freshwater for 3 hours
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1000 mg/L buffered MS‐222 for 15 minutes, then placed in freshwater for 18 hours
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1000 mg/L buffered MS‐222 for 60 minutes, then placed in freshwater for 3 hours
Number of subjects: 24
Study: 34534897

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich diet (PR-diet)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 51
Study: 35285282

Group type: EXPERIMENTAL
Intervention: Educational intervention (ten 1-hour sessions, twice weekly)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 32028900

Group type: EXPERIMENTAL
Intervention: Smoking (22 smokers)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-smokers (27 non-smokers)
Number of subjects: 49
Study: 35443843

Group type: EXPERIMENTAL
Intervention: Exergaming
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional exercises
Number of subjects: 36
Study: 33956256

Group type: EXPERIMENTAL
Intervention: Trehalose/sodium hyaluronate eye drops b.i.d (Group A)
Number of subjects: 135

Group type: COMPARATOR
Intervention: 0.9% unpreserved sodium chloride eye drops b.i.d (Group B)
Number of subjects: 135
Study: 32421353

Group type: EXPERIMENTAL
Intervention: Intrapleural fibrinolytic therapy (IPFT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Early medical thoracoscopy (MT)
Number of subjects: 32
Study: 36084154

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 180
Study: 32014032

Group type: EXPERIMENTAL
Intervention: S44819 150 mg bid
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: S44819 300 mg bid
Number of subjects: 580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580
Study: 36054369

Group type: EXPERIMENTAL
Intervention: Mometasone furoate intranasal spray
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sodium chloride intranasal spray (placebo)
Number of subjects: 80
Study: 34099390

Group type: EXPERIMENTAL
Intervention: Just Do You engagement program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 34510966

Group type: EXPERIMENTAL
Intervention: Counseling sessions (3 sessions)
Number of subjects: 70
Study: 33508918

Group type: EXPERIMENTAL
Intervention: nCRT (XELOX chemotherapy: capecitabine + oxaliplatin) with concurrent radiotherapy (45 Gy, 25 times, 1.8 Gy/d, 5 times/week)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: nCRT (XELOX chemotherapy: capecitabine + oxaliplatin)
Number of subjects: 150
Study: 32819528

Group type: EXPERIMENTAL
Intervention: Contact force–guided radiofrequency ablation
Number of subjects: 346

Group type: COMPARATOR
Intervention: Cryoballoon ablation
Number of subjects: 346
Study: 35820547

Group type: EXPERIMENTAL
Intervention: Deucravacitinib 6 mg daily
Number of subjects: 666

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily
Number of subjects: 666
Study: 34639109

Group type: EXPERIMENTAL
Intervention: Vaginal injection of recombinant human follicle-stimulating hormone (rhFSH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abdominal injection of recombinant human follicle-stimulating hormone (rhFSH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily abdominal or vaginal injections of rhFSH (1 IU twice daily for 4 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent vaginal injections of rhFSH (4 IU every other day for two doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermittent abdominal or vaginal injections of rhFSH
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34358713

Group type: EXPERIMENTAL
Intervention: intermittent Theta Burst Stimulation (iTBS) over bilateral posterior superior temporal sulcus (pSTS) for 5 consecutive days
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: intermittent Theta Burst Stimulation (iTBS)
Number of subjects: 13

Group type: COMPARATOR
Intervention: sham control (inion)
Number of subjects: 13
Study: 34285426

Group type: EXPERIMENTAL
Intervention: 1.25 mg intravitreal bevacizumab
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 1 mg intravitreal triamcinolone
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 1.25 mg bevacizumab and 1 mg intravitreal triamcinolone (combined treatment)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study: 616886751

Group type: EXPERIMENTAL
Intervention: PDCA intervention
Number of subjects: 92
Study: 34855039

Group type: EXPERIMENTAL
Intervention: Stepped-care approach
Number of subjects: 15

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 15
Study: 32901432

Group type: EXPERIMENTAL
Intervention: Modafinil/armodafinil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Traditional psychostimulants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Solriamfetol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitolisant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium oxybate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0
Study: 32454078

Group type: EXPERIMENTAL
Intervention: Eating situation at friend's place
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Eating situation at home
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Eating situation at a restaurant abroad
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Eating situation at a domestic restaurant
Number of subjects: 1046
Study: 34029235

Group type: EXPERIMENTAL
Intervention: Eccentric exercises with extracorporeal shockwave therapy (SWT group)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Eccentric exercises with sham shockwave therapy (control group)
Number of subjects: 119
Study: 32856146

Group type: EXPERIMENTAL
Intervention: Short-term stenting (Group B)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Long-term stenting (Group A)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 62
Study: 35060868

Group type: EXPERIMENTAL
Intervention: Stress inoculation training (Breathe, Talk, See, Focus mental performance tool)
Number of subjects: 61
Study: 34301749

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 215

Group type: COMPARATOR
Intervention: Physician's choice chemotherapy (PC)
Number of subjects: 215
Study: 32186523

Group type: EXPERIMENTAL
Intervention: Desoximetasone spray 0.25% for 2 weeks with twice-daily telephone call reminders
Number of subjects: 12

Group type: COMPARATOR
Intervention: Desoximetasone spray 0.25% for 2 weeks without reminders
Number of subjects: 12
Study: 35813434

Group type: EXPERIMENTAL
Intervention: Transesophageal ultrasound monitoring using ONLM algorithm with optimal pulmonary compliance titration of PEEP.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fixed PEEP=5 cmH2O in control group.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ONLM algorithm compared to NLM and Bayes Shrink denoising algorithm.
Number of subjects: 120
Study: 33070176

Group type: EXPERIMENTAL
Intervention: Pyrazinamide AUC/MIC below 8.42
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Pyrazinamide AUC/MIC below 2.79
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Rifampicin AUC/MIC below 435.45
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Isoniazid AUC >21.78 mg · h/L
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Rifampicin AUC >82.01 mg · h/L
Number of subjects: 220
Study: 35785423

Group type: EXPERIMENTAL
Intervention: Hard splint therapy
Number of subjects: 91

Group type: COMPARATOR
Intervention: Soft splint therapy
Number of subjects: 91
Study: 33434035

Group type: EXPERIMENTAL
Intervention: Conidia suspension with a concentration of 5×10^5/ml sprayed on fruits; maintained high humidity for 3 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6
Study: 32795283

Group type: EXPERIMENTAL
Intervention: Treat-to-target physiotherapy strategy
Number of subjects: 624

Group type: COMPARATOR
Intervention: Usual postoperative care
Number of subjects: 624
Study: 33978983

Group type: EXPERIMENTAL
Intervention: Benralizumab
Number of subjects: 153
Study: 33252568

Group type: EXPERIMENTAL
Intervention: OA-CXL (accelerated CXL with systemic oxygen at 5 L/min for 10 minutes)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: OA-CXL
Number of subjects: 47

Group type: COMPARATOR
Intervention: A-CXL (accelerated CXL without supplemental oxygen)
Number of subjects: 47

Group type: COMPARATOR
Intervention: C-CXL (conventional CXL according to the Dresden protocol)
Number of subjects: 47
Study: 35014128

Group type: EXPERIMENTAL
Intervention: Echocardiography-guided therapy with spironolactone
Number of subjects: 349

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 349
Study: 33309030

Group type: EXPERIMENTAL
Intervention: MR holographic guidance (MRHG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (routine 3D reconstruction)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: MRHG
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 35147387

Group type: EXPERIMENTAL
Intervention: Partial Nephrectomy (PN)
Number of subjects: 13177

Group type: COMPARATOR
Intervention: Radical Nephrectomy (RN)
Number of subjects: 13177
Study: 33626248

Group type: EXPERIMENTAL
Intervention: Hypothermic oxygenated machine perfusion
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional static cold storage
Number of subjects: 160
Study: 36495882

Group type: EXPERIMENTAL
Intervention: nOPV2
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study: 34375393

Group type: EXPERIMENTAL
Intervention: Lifestyle therapy plus testosterone (LT+Test)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Lifestyle therapy plus placebo (LT+Pbo)
Number of subjects: 83
Study: 32436455

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus ASA 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: ASA 100 mg
Number of subjects: 0
Study: 35060222

Group type: EXPERIMENTAL
Intervention: Untire app intervention
Number of subjects: 799

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 799
Study: 34370916

Group type: EXPERIMENTAL
Intervention: Experimental stannous-containing dentifrice (n=43)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Positive control dentifrice (n=43)
Number of subjects: 87
Study: 33636648

Group type: EXPERIMENTAL
Intervention: Lemborexant 5 mg (LEM5)
Number of subjects: 949

Group type: EXPERIMENTAL
Intervention: Lemborexant 10 mg (LEM10)
Number of subjects: 949

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 949
Study: 32682347

Group type: EXPERIMENTAL
Intervention: 0.5 mg melatonin taken 1 hour before desired bedtime for 4 weeks (5-7 nights/week)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 0.5 mg melatonin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 34989803

Group type: EXPERIMENTAL
Intervention: Razuprotafib BID + latanoprost
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Razuprotafib QD + latanoprost
Number of subjects: 194

Group type: COMPARATOR
Intervention: Latanoprost monotherapy
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Razuprotafib BID + latanoprost after 14 days
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Conjunctival hyperemia
Number of subjects: 194
Study: 33976533

Group type: EXPERIMENTAL
Intervention: Zonisamide 25 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zonisamide 50 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zonisamide (both dosages)
Number of subjects: 0
Study: 33593828

Group type: EXPERIMENTAL
Intervention: Liquid immune profile-based signature (LIPS) based on five immune cell subtypes: CD14 high monocytes, CD8+/PD-1 + T cells, plasmacytoid dendritic cells, neutrophils, and CD3 + /CD56 + /CD16 + natural killer (NK)T cells.
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Liquid immune profile-based signature (LIPS)
Number of subjects: 104
Study: 32898787

Group type: EXPERIMENTAL
Intervention: Calorie-restricted diet plus 109 CFU synbiotic supplement (CRS group; n = 45)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (CRP group; n = 45)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (n = 45) with no intervention
Number of subjects: 135
Study: 35864343

Group type: EXPERIMENTAL
Intervention: Vibration Training (VT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 65
Study: 32144884

Group type: EXPERIMENTAL
Intervention: Knee Arthroplasty (KA) for African American participants
Number of subjects: 384

Group type: COMPARATOR
Intervention: Knee Arthroplasty (KA) for non-African American participants
Number of subjects: 384
Study: 32338441

Group type: EXPERIMENTAL
Intervention: Lung protective ventilation (LPV)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 77
Study: 35715184

Group type: EXPERIMENTAL
Intervention: Elagolix 200 mg two times per day for 8 weeks
Number of subjects: 814

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 814
Study: 32677855

Group type: EXPERIMENTAL
Intervention: Warfarin treatment
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Warfarin dosing algorithm for patients older than 60
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Concomitant torasemide
Number of subjects: 379
Study: 37676213

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 34959779

Group type: EXPERIMENTAL
Intervention: Mixed-tocopherol 400 IU/day
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32548854

Group type: EXPERIMENTAL
Intervention: CGRP infusion
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Baseline S100B levels in eCHa patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: NSE levels in active disease phase
Number of subjects: 31
Study: 34922865

Group type: EXPERIMENTAL
Intervention: AI classification tool
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard interpretation without AI
Number of subjects: 0
Study: 34126419

Group type: EXPERIMENTAL
Intervention: Shenhuang Granule (SHG) administered twice a day for 14 days
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 111
Study: 32092098

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (IVR) in conjunction with Propofol patient-controlled sedation (PCS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol patient-controlled sedation (PCS) alone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups (IVR and control)
Number of subjects: 50
Study: 33657757

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Suit therapy
Number of subjects: 46
Study: 37814228

Group type: EXPERIMENTAL
Intervention: Clinical radiomics nomogram
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Radiomics model
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA)
Number of subjects: 113
Study: 33692176

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive-behavioral therapy (CBT) for severe irritability, with 12 active treatment sessions following a baseline observation period of 2, 4, or 6 weeks.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive-behavioral therapy (CBT) for severe irritability.
Number of subjects: 40
Study: 32946574

Group type: EXPERIMENTAL
Intervention: SJX-653 30 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: SJX-653 60 mg
Number of subjects: 42
Study: 35273276

Group type: EXPERIMENTAL
Intervention: Multifaceted educational intervention in intervention hospitals
Number of subjects: 6576

Group type: COMPARATOR
Intervention: Feedback of quality indicators in control hospitals
Number of subjects: 6576

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 6576
Study: 34769906

Group type: EXPERIMENTAL
Intervention: Elastic resistance exercises with Proprioceptive Neuromuscular Facilitation (PNF) for eight weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no exercises)
Number of subjects: 30
Study: 34110494

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk Fill (TB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Filtek Ultimate (FU)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 33393484

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM) for 3 weeks, 45-minute daily sessions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (medical therapy only)
Number of subjects: 60
Study: 33074729

Group type: EXPERIMENTAL
Intervention: Insulin deprivation and LPS injection
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Total insulin deprivation for 9 hours
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 3-hydroxybutyrate (OHB) infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 27

Group type: COMPARATOR
Intervention: Insulin-controlled euglycemia
Number of subjects: 27
Study: 32444190

Group type: EXPERIMENTAL
Intervention: Web-based diabetes education
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 80
Study: 34984786

Group type: EXPERIMENTAL
Intervention: Eversense real‐time continuous glucose monitoring (CGM) system
Number of subjects: 239

Group type: COMPARATOR
Intervention: Self‐monitoring of blood glucose or intermittently scanned CGM
Number of subjects: 239
Study: 33128696

Group type: EXPERIMENTAL
Intervention: Disease-modifying anti-rheumatic drugs (DMARDs) and biologic agents
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (individuals without RDs)
Number of subjects: 0
Study: 32331817

Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 369

Group type: COMPARATOR
Intervention: Lobectomy
Number of subjects: 369